Charlie Bachtell: The Inside Story of Cresco Labs & Impact of Rescheduling
"Giant… That's a giant advantage."
Cresco Labs may mirror other Tier 1 MSOs on the surface, but once you explore deeper, you'll discover their unique edge. They've built sophisticated systems and technology that set them apart and enable a nuanced understanding of market conditions. This advanced business intelligence approach significantly narrows risk aperture, proactively allowing Cresco to identify and capitalize on market trends.
This week, we sit down with Charlie Bachtell to discuss:
- Implications of Rescheduling, 280E & Interstate Commerce
- Cresco Labs' hidden compounding unique differentiator
- 2024 Roadmap: Focusing on FL, Ohio, Penn, NY
- Pivotal role of data in shaping their business strategy
About Cresco Labs:
Cresco Labs is one of the largest publicly traded, vertically integrated, multistate cannabis companies in the U.S. We produce the industry’s #1 portfolio of cannabis brands and operate dispensaries under our Sunnyside brand nationally that focus on delivering consumer education, trust and convenience.
Guest Links:
https://twitter.com/CharlesBachtell
https://twitter.com/crescolabs
https://www.linkedin.com/company/cresco-labs/
https://www.crescolabs.com/
#MSOS #CrescoLabs #CRLBF
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
The Dime is a top 5% most shared global podcast
The Dime is a top 50 Cannabis Podcast
Sign up for our playbook here:
🎥 YouTube: The Dime
📸 Instagram: The Dime